To include your compound in the COVID-19 Resource Center, submit it here.

Armo reports additional Phase Ib data for AM0010 in pancreatic cancer

Armo BioSciences Inc. (Redwood City, Calif.) reported data from 34 evaluable patients with advanced pancreatic ductal adenocarcinoma in a Phase Ib trial in 352 patients with advanced

Read the full 276 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE